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Tissue-specific removal of c-jun from epidermal cells
in mice leads to a failure of eyelid fusion during
embryogenesis and reveals roles for c-Jun in wound
repair and tumorigenesis in adult skin. This has
provided a definitive test of the in vivo function of 
AP-1 signalling and shown that EGF signalling is key
to all of c-Jun’s roles in the epidermis.
The dimeric transcription factor complex AP-1 has been
implicated in the control of a diverse range of biological
processes, including cell proliferation, differentiation,
apoptosis and oncogenic transformation [1]. AP-1 com-
plexes are formed from members of the Fos, Jun and
ATF protein families, and transduce extracellular signals
into a transcriptional readout by binding to AP-1 recog-
nition sites upstream of target genes. The functions of
various AP-1 family members have in part been
revealed by studies of genetically modified mice, but
the in vivo study of c-Jun function has been hampered
by the heart and liver defects that kill knockout
embryos half way through gestation [2].
Two groups [3,4] have now taken a Cre–lox approach
to knocking out c-jun function in a tissue-specific
manner. By engineering mice where the c-jun gene is
flanked by loxP sites, and crossing these with mice
expressing Cre recombinase under the control of a pro-
moter specific for basal keratinocytes — from the gene
for keratin 14 in one study, and for keratin 5 in the other
— they specifically deleted the c-jun gene throughout
the skin, generating K14cre:c-jun∆ep [3] and K5cre:c-
jun∆ep [4] mice, respectively. Thus, the two groups cir-
cumvented the problem of embryonic lethality and were
able to address the role of c-Jun in both late foetal and
adult epidermis. Both groups found that, while stratifi-
cation of the developing epidermis was unperturbed,
loss of c-Jun in the epidermis led to dramatic failure of
eyelid fusion during embryogenesis, resulting in mice
born with open eyes. In contrast, wild-type siblings seal
their eyes around day 16 of gestation and do not open
them again until two weeks after birth.
Knockout mouse studies have implicated several sig-
nalling cascades in eyelid closure. For example, epi-
dermal growth factor (EGF) receptor null mice are born
with open eyes [5–8], and indeed both new c-Jun
knockout studies [3,4] found that failure of eyelid
closure correlates with decreased expression and acti-
vation of the EGF receptor. Several other insights into
the function of c-Jun came from studying primary ker-
atinocytes isolated from both lines of mutant mice. Cul-
tured c-jun null keratinocytes appear to have reduced
proliferative capacity in comparison to wild type; they
also show increased expression of the differentiation
marker keratin 10, concomitant with an increased rate
of apoptosis [4]. The expression levels of both the EGF
receptor and its ligand heparin-binding EGF (HB-EGF)
were found to be reduced, while the levels of two other
EGF receptor ligands, amphiregulin and transforming
growth factor-α (TGF-α), were unchanged [4].
Interestingly, all the differences in proliferation and
differentiation could be rescued by conditioned medium
from control keratinocytes, or by the addition of growth
factors that have been shown to act in an autocrine
(EGF, TGF-α, HB-EGF) or paracrine (keratinocyte growth
factor, granulocyte monocyte-colony stimulating factor)
manner. Earlier studies showed that EGF receptor sig-
nalling can negatively regulate keratinocyte differentia-
tion [8]. The reduced EGF receptor signalling in mutant
keratinocytes may thus cause increased differentiation
and a depletion of cells from the proliferative pool.
These findings implicate c-Jun in a positive feedback
loop in which activation of EGF receptor by its ligand
HB-EGF leads to c-Jun (AP-1)-mediated activation of
target genes encoding proteins that will in turn further
potentiate EGF receptor activation (Figure 1). In addi-
tion to regulating expression of the receptor, AP-1 acts
to control EGF receptor activation by regulating the
availability of its ligand HB-EGF, which has AP-1-
binding sites in its promoter [9]. Further regulation may
come via AP-1-responsive matrix metalloproteinases
controlling the cleavage and release of HB-EGF from
the extracellular matrix, freeing the ligand to bind to the
EGF receptor [10]. Support for the existence of such an
autocrine loop controlling EGF receptor activation
comes from scratch wound studies on primary ker-
atinocytes isolated from K14cre:c-jun∆ep mice [3]. The
mutant keratinocytes failed to migrate properly in
scratch assays because of their inability to activate the
EGF receptor, but receptor phosphorylation was
rescued by supplementing mutant cells with either con-
ditioned medium from control keratinocytes or recom-
binant HB-EGF.
Clues as to how a failure in EGF receptor signalling
can prevent eyelid fusion came from transmission elec-
tron microscopy. Micrographs of sections through wild-
type eyes revealed that filopodia bridge the gap
between the epithelial fronts where the eyelids come
into apposition. In contrast, the few filopodia present in
c-jun null eyelids look abnormal and stunted [4]. Eyelid
fusion is one of several morphogenetic processes
occurring during mammalian embryogenesis in which
two epithelial fronts have to zipper shut. Others include
neural tube closure, palate fusion and cloacal fusion
[11], and all of these have much in common with an
episode of epithelial fusion called dorsal closure that
occurs late in Drosophila embryogenesis and also crit-
ically depends on filopodia (Figure 2). If filopodial for-
mation is blocked in stripes by expression of a
dominant-negative form of Cdc42, under the control of
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the promoter of the fly segmentation gene engrailed,
the fusion process fails in the filopodial-free epithelial
stripes [12]. Just as in the mouse eyelid, Jun signalling
seems critical for dorsal closure in flies; in hemipterous
mutant embryos, which lack the fly Jun amino-terminal
kinase kinase, dorsal closure fails at precisely the stage
where filopodia are first detected on cells of the leading
edge [12,13]. These two morphogenetic movements —
eyelid closure in the mouse and dorsal closure in the fly
— may thus be regulated by fundamentally the same
signalling system.
The two c-jun knockouts showed the same eyelid phe-
notype, but the authors [3,4] drew different conclusions
about the capacity of their mice to heal wounds. The
wound healing process involves expression of a plethora
of growth factors and cytokines [14], many of which are
regulated by AP-1, and so it is not expected that these
mutant mice would have a wound healing phenotype.
Zenz et al. [4], however, found that 5 mm excisional
wounds healed with the same kinetics in control and
K5cre:c-jun∆ep mice; both were re-epithelialised by 10
days post-wounding. In contrast, Li et al. [3] observed a
late stage delay in the repair of 6 mm excisional wounds,
first evident at around day 9 and persisting up to day 13
post-wounding, the latest stage examined. 
This difference in repair capacity might, of course,
easily be the result of differences in the genetic
background of the mice used in the two studies [3,4], or
slight differences in the efficiency of Cre-mediated
recombination, with the phenotype being relatively mild
because c-Jun’s absence is rescued by another
member of the Jun family [15]. It is tempting, however,
to speculate that the late stage delay in wound repair
revealed by the K14cre:c-jun∆ep mice might mirror a
similar failure in the latest stages of repair when
Drosophila embryos were laser-wounded but prevented
from assembling filopodia by the expression of domi-
nant-negative Cdc42 [16]. In these studies, epithelial
repair progresses at normal pace, but the final knitting
together of the fly epidermis fails in the absence of
filopodia. It might be interesting to analyse sections
from late stage mouse wounds using transmission elec-
tron microscopy, to see whether filopodia are present in
the wild-type epidermis and runted in the c-jun mutant.
Besides involvement in eyelid closure and wound
repair, AP-1 proteins have previously been implicated in
several aspects of tumorigenesis: AP-1 is thought to
regulate oncogenic transformation, proliferation, apop-
tosis, invasion and angiogenesis [1]. Previously, it 
was shown that blocking c-Jun function in basal
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Figure 1. A positive feedback loop con-
trolling EGF receptor activation.
Classical MAP kinase pathways down-
stream of EGF receptor activation lead to
upregulation of target genes via c-Jun-
containing AP-1 complexes. Among these
targets are at least three key components
of EGF receptor activation: EGF receptor
itself, its ligand HB-EGF and matrix
metalloproteinases that release HB-EGF
from heparin at the cell surface, allowing
it to bind to the EGF receptor and com-
plete the positive feedback loop. Cell membrane
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keratinocytes resulted in decreased papilloma formation
in a two-stage skin carcinogenesis model [17]. But treat-
ing the skin of mice with impaired epidermal c-Jun with
phorbol ester — a growth-promoting chemical used as
part of a classical skin carcinogenesis model — showed
that c-Jun is not essential for the proliferative response
of keratinocytes seen following treatment [3,17],
Earlier studies found that K5-SOS transgenic mice, in
which a dominant active form of the Ras guanine
nucleotide exchange factor Son of sevenless (SOS) was
expressed under the control of the keratin 5 promoter,
developed spontaneous skin tumours [18]. These mice
showed constitutive activation of the Ras signalling
pathway, which acts downstream of the EGF receptor
to drive cell proliferation. Crossing the K5-SOS mice
onto an EGF receptor-deficient background abrogated
the negative effect of EGF receptor signalling on ker-
atinocyte differentiation, causing increased differentia-
tion, decreased proliferation and consequent reduction
in papilloma size [18]. c-Jun is implicated as a mediator
of this tumorigenic effect of EGF receptor signalling, as
crossing K5-SOS mice with junAA mice — which have
a form of c-Jun that cannot be phosphorylated — also
decreased tumor size [19, 20]. In line with these previ-
ous studies, one of the recent c-jun knockout papers
reported that crossing K5-SOS mice with K5cre:c-jun∆ep
mice also results in a decrease in papilloma size [4].
These new studies have definitively tested the in vivo
roles of c-Jun and AP-1 signalling in the skin by tissue
specific gene-targeting. They have shown a critical role
for the EGF receptor, signalling via c-Jun, in controlling
eyelid development, keratinocyte proliferation and skin
tumor formation. 
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Figure 2. Filopodial dependent epithelial
fusion during embryogenesis.
Cartoons of foetal mouse eyelid closure
and Drosophila embryo dorsal closure
highlight the similarities seen at the cellu-
lar level. Where epithelial fronts meet,
filopodia of opposing epithelial cells inter-
digitate and form weak adhesions. Filopo-
dia subsequently regress, zippering the
two fronts together (arrows). 
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